Presenters:
CEO Dr. Erik Digman Wiklund will provide a company update and information related to the upcoming warrant exercise period
CTO Dr. Thomas Birkballe Hansen will present the most recent circVec in vitro and in vivo data and an overview of Circio´s R&D strategy
